Success Stories: Expedited EB-1A Case Got Approval in Just 10 Days for A Principal Research Associate with the Help of PP Service

Client’s Testimonial:

“I have just finished the I-140 procedure, so far it is being made with good caution and knowledge. Thank you for helping with my questions and documentation.”

On March 19^th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Principal Research Associate in the Field of Molecular Biology (Approval Notice).

General Field: Molecular Biology

Position at the Time of Case Filing: Principal Research Associate

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: March 19^th, 2021

Processing Time: 10 days (Premium Processing Requested)

Case Summary:

Our client, a principal research associate with an M.S. degree in vaccine development and pharmaceutical approaches, and researching the field of molecular biology approached North America Immigration Law Group to help her in building an influencing EB-1A (Alien of Extraordinary Ability) petition to move a major step closer to green card success. Since EB-1A is one of the toughest I-140 visa categories, we made sure of adding only the relevant details of our client’s accomplishments in her petition packet. Just 10 days after we filed the petition on her behalf, the USCIS permitted the case approval.

While preparing her case, we aimed at outlining her proposed research focusing on vaccine programs that facilitate and improve vaccine development for an array of diseases. After a thorough review, we concluded that her research addresses some of our nation’s and the world’s most pressing issues, including the exorbitant costs of treating HIV and the extensive losses incurred by ovarian cancer-related deaths. Therefore, her continued support in the United States is critical to the overall success of the clinical, pharmaceutical, and public health industries in the United States.

Her petition packet also consisted of the 8 peer-reviewed scientific journal articles and 2 conference abstracts she published in some of the most perceptive journals in the field, and we highlighted her work which has been cited by many researchers in the field, resulting in 1,500 citations from 55 countries, signifying her bright reputation that has sparked trust in her work nationally and internationally in the field.

Moreover, she had conducted 15 peer reviews for highly acclaimed journals and conferences, confirming her active participation as a critic in the scientific community in the molecular biology field.

We included four letters of recommendation that she got signed by other well-known researchers in the field to corroborate her built case further. One of her recommenders stated:

“These are remarkable achievements that noticeably advance the cause of preventing and eventually curing HIV. [Client’s] research thus directly contributes to improving health care outcomes in the United States by pioneering new treatments for this deadly disease. Her innovative and original contributions distinguish her as one of the top scientists in her area of research.”

After compiling all the required information in her petition packet, we submitted it to the USCIS, establishing that our client qualifies as an alien of extraordinary ability and she deserves to continue her work in the United States. Thanks to premium processing, she achieved her EB-1A petition approval in just 10 days. We truly thank our client for choosing us for representing her EB-1A application and congratulate her on this achievement.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.